This review examines how immune interactions shape MASLD progression and surveys immune-targeted therapies for researchers and clinicians.
Key Takeaways
- You have multiple emails registered with Frontiers: You don't have a Frontiers account ?
- You can register here Metabolic dysfunction-associated fatty liver disease (MASLD)
- Distribution or reproduction in other forums is permitted